Market Cap 3.35B
Revenue (ttm) 27.12M
Net Income (ttm) -239.56M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -883.33%
Debt to Equity Ratio -12.96
Volume 1,527,552
Avg Vol 3,817,424
Day's Range N/A - N/A
Shares Out 54.87M
Stochastic %K 45%
Beta 0.56
Analysts Strong Sell
Price Target $75.50

Company Profile

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial t...

Industry: Biotechnology
Sector: Healthcare
Phone: 31 20 240 6000
Address:
Paasheuvelweg 25, Amsterdam, Netherlands
Lincoln1962
Lincoln1962 Oct. 27 at 4:57 PM
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Oct. 27 at 4:12 PM
$QURE this is primed and ready to be bought.
0 · Reply
Albino_Trader123
Albino_Trader123 Oct. 27 at 2:03 PM
$QURE Looks ready here. Have some longs in
0 · Reply
snowboy
snowboy Oct. 26 at 4:31 PM
$CAPR Busy couple of weeks upcoming for Linda and team. Please remember that the gene nerds at $SRPT and others will be needed for true cures. Once concept of exosome-based treatment proved, work will start on using StealthX platform to float gene therapies to muscles so that the damned AAV vectors and their incipient side effects can be ditched. ​For instance, $QURE will be able to float Huntingdon gene fix to brain using IV administered exosome carrier, eliminating manual placement in brain via surgery. I am remaining incredibly long investor from here... $40 billion MC or buyout. 30 minutes to kickoff. See ya at Thanksgiving.
0 · Reply
Jadek6
Jadek6 Oct. 26 at 2:58 PM
$QURE ..poor little DOOM ..caught in his repeated CON's
0 · Reply
Jadek6
Jadek6 Oct. 26 at 1:59 PM
$QURE. Con man is back ..he is already selling , posters !!!
1 · Reply
MF__DOOM
MF__DOOM Oct. 25 at 10:52 PM
0 · Reply
HScottMatusow
HScottMatusow Oct. 25 at 12:05 AM
It's actually kinda funny reading X and Stocktwit posts from bears on $QURE. If you going to attempt a bear case, stop using data from 2 years ago, use current data, and stop calling Gene Therapy "a drug." Thank you for playing! $XBI $IBB $IWM $SPY
0 · Reply
UnicornProfits
UnicornProfits Oct. 24 at 8:33 PM
What is happening to ticker CMCT right now?! CMCT is breaking out like crazy.. Are they pumping up ticker CMCT for 300% today!? Its insane what's going on in this market.. Looks like all eyes are moving to CMCT now.. Watching: $NEON $LAC $QURE $PLRZ bought dips
1 · Reply
Okadarlan
Okadarlan Oct. 22 at 2:26 PM
$QURE ok i short here.
0 · Reply
Latest News on QURE
uniQure Stock Jumps On Positive News, But Risks Remain

Sep 25, 2025, 7:23 AM EDT - 4 weeks ago

uniQure Stock Jumps On Positive News, But Risks Remain


UniQure: How QURE Stock Rises 10x To $500?

Sep 25, 2025, 6:20 AM EDT - 4 weeks ago

UniQure: How QURE Stock Rises 10x To $500?


uniQure Announces $200 Million Proposed Public Offering

Sep 24, 2025, 4:06 PM EDT - 4 weeks ago

uniQure Announces $200 Million Proposed Public Offering


uniQure N.V. - Special Call

Sep 24, 2025, 1:03 PM EDT - 4 weeks ago

uniQure N.V. - Special Call


QURE stock skyrockets 200% on ‘three' big news

Sep 24, 2025, 11:20 AM EDT - 4 weeks ago

QURE stock skyrockets 200% on ‘three' big news


uniQure N.V. (QURE) Q2 2025 Earnings Call Transcript

Jul 29, 2025, 9:07 PM EDT - 3 months ago

uniQure N.V. (QURE) Q2 2025 Earnings Call Transcript


uniQure to Announce Second Quarter 2025 Financial Results

Jul 22, 2025, 7:05 AM EDT - 3 months ago

uniQure to Announce Second Quarter 2025 Financial Results


uniQure's AMT-130 Gene Therapy Warrants An Upgrade

May 28, 2025, 4:56 AM EDT - 5 months ago

uniQure's AMT-130 Gene Therapy Warrants An Upgrade


uniQure N.V. (QURE) Q1 2025 Earnings Call Transcript

May 9, 2025, 10:16 PM EDT - 6 months ago

uniQure N.V. (QURE) Q1 2025 Earnings Call Transcript


uniQure to Announce First Quarter 2025 Financial Results

May 5, 2025, 4:05 PM EDT - 6 months ago

uniQure to Announce First Quarter 2025 Financial Results


uniQure N.V.: A Potential Huntington's Play

Feb 26, 2025, 1:47 AM EST - 8 months ago

uniQure N.V.: A Potential Huntington's Play


uniQure Announces Pricing of its Public Offering

Jan 8, 2025, 7:05 AM EST - 10 months ago

uniQure Announces Pricing of its Public Offering


uniQure Announces Proposed Public Offering

Jan 7, 2025, 4:49 PM EST - 10 months ago

uniQure Announces Proposed Public Offering


Final Trade: DVN, QURE, GOOGL, DFH

Dec 30, 2024, 6:31 PM EST - 10 months ago

Final Trade: DVN, QURE, GOOGL, DFH

GOOG GOOGL DFH DVN


Lincoln1962
Lincoln1962 Oct. 27 at 4:57 PM
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Oct. 27 at 4:12 PM
$QURE this is primed and ready to be bought.
0 · Reply
Albino_Trader123
Albino_Trader123 Oct. 27 at 2:03 PM
$QURE Looks ready here. Have some longs in
0 · Reply
snowboy
snowboy Oct. 26 at 4:31 PM
$CAPR Busy couple of weeks upcoming for Linda and team. Please remember that the gene nerds at $SRPT and others will be needed for true cures. Once concept of exosome-based treatment proved, work will start on using StealthX platform to float gene therapies to muscles so that the damned AAV vectors and their incipient side effects can be ditched. ​For instance, $QURE will be able to float Huntingdon gene fix to brain using IV administered exosome carrier, eliminating manual placement in brain via surgery. I am remaining incredibly long investor from here... $40 billion MC or buyout. 30 minutes to kickoff. See ya at Thanksgiving.
0 · Reply
Jadek6
Jadek6 Oct. 26 at 2:58 PM
$QURE ..poor little DOOM ..caught in his repeated CON's
0 · Reply
Jadek6
Jadek6 Oct. 26 at 1:59 PM
$QURE. Con man is back ..he is already selling , posters !!!
1 · Reply
MF__DOOM
MF__DOOM Oct. 25 at 10:52 PM
0 · Reply
HScottMatusow
HScottMatusow Oct. 25 at 12:05 AM
It's actually kinda funny reading X and Stocktwit posts from bears on $QURE. If you going to attempt a bear case, stop using data from 2 years ago, use current data, and stop calling Gene Therapy "a drug." Thank you for playing! $XBI $IBB $IWM $SPY
0 · Reply
UnicornProfits
UnicornProfits Oct. 24 at 8:33 PM
What is happening to ticker CMCT right now?! CMCT is breaking out like crazy.. Are they pumping up ticker CMCT for 300% today!? Its insane what's going on in this market.. Looks like all eyes are moving to CMCT now.. Watching: $NEON $LAC $QURE $PLRZ bought dips
1 · Reply
Okadarlan
Okadarlan Oct. 22 at 2:26 PM
$QURE ok i short here.
0 · Reply
stockwitsuser2449
stockwitsuser2449 Oct. 20 at 6:05 PM
$HUMA I want to one day wake up and see this pass $QURE :)
0 · Reply
daticecold
daticecold Oct. 20 at 5:58 PM
$QURE People who are short this stock shouldn't be allowed to operate heavy machinery.
0 · Reply
biotech
biotech Oct. 20 at 5:37 PM
1 · Reply
pnchv59
pnchv59 Oct. 20 at 2:16 PM
$QURE Big buy orders 😳
0 · Reply
SlovedJBandMe
SlovedJBandMe Oct. 20 at 10:17 AM
$QURE Why is QURE showing up as QUOTE on my feed????
0 · Reply
LarsonLE1
LarsonLE1 Oct. 20 at 2:59 AM
$QURE bye bye bears
1 · Reply
CantNameThatTune
CantNameThatTune Oct. 19 at 2:35 PM
$RANI $ASMB $QNRX $QURE $IMRX But let's take it a step farther... RANI pre-funded warrants 82 million @ $.48 and exercisable at $.0001 ASMB pre funded warrants Class A + B prefunded warrants at $19.60 below the $21.60 offer price QNRX pre funded warrants This is a nightmare. Series H, I, J, K prefunded warrants for $88 million QURE pre funded warrants 526K @$47.50 and exercisable at $.0001 IMRX pre funded warrants on 8/21 as part of $25 mil PP (secret investor) at $3.95, with option in at $5.50. Stock walks 4.70 to new highs $10+. Then another round on 9/25 with Sanofi $25 mil PP at $9.23 on the heels of "extroardinary" results per the company. For this one, stock more than doubles on a $25 mil private placement to unknown investor. Then a month later they announce another $25 mil private placement from Sanofi and stock drops 40%. Who really knows anything at this point!
0 · Reply
CantNameThatTune
CantNameThatTune Oct. 19 at 11:44 AM
Let's look at the biotech landscape: $RANI Licensing deal Fri w/Chugai ($CHGCY). $60 mil PIPE w/pre-funded warrants. Up 250%. No trial results $ASMB (Hep B+D) 8/25 announces 94% reduction in Hep at 350 mil dose. Announces $175 mil offer at $19.60 with Gilead separate $45 mil at $19.60. Never went red. New 52 highs Fri @ $30.20 $QNRX (Netherton -extremely rare) No trial news. Announces PP on 10/10 in $7's. Stock runs to $41. Now $16's. Up more than 100% $QURE (Huntingtons - extremely rare) on 9/24 announces some trial progression for AMT-130. Stock runs $13's to $50 . Immed announce $200 mil offering. Upsized to $350 mil. Stock hits new 52's last wk $64. $IMRX (Pancreatic cancer) On 9/25 announces world's best survival rate at 6 mos of 94%. Further announcing survival rate of 86% at 9 mos vs. only FDA approved 42% in the market. Announces $175 mil offering with PP from Sanofi $25 mil. Identical to ASMB. Offering & placement @ $9.23 (no discount). Stock now $5.58
1 · Reply
Paraboljoker
Paraboljoker Oct. 18 at 3:16 PM
$SUGP continues to stand out as one of the cleanest small-cap structures on the market. ✅ Market Cap: Only ~$12.5M ✅ Float: ~0.4M shares — ultra low supply ✅ Cash Need: Low ✅ Overall Risk: Low ✅ Overhead Supply: Low ✅ Estimated Net Cash/Share: $2.97 With minimal dilution risk and positive revenue growth, SUGP is positioned perfectly for a potential momentum run once liquidity returns to the name. This is the type of setup traders look for — tight float, solid fundamentals, clean balance sheet, and real business operations. If growth continues alongside contract expansion, this could reprice quickly. $OPEN $SLNH $QURE $IVF
0 · Reply
Dkll303
Dkll303 Oct. 18 at 1:04 PM
$QURE $SGMO $TSHA cantor is the world's worst at very thing they touch , including but not limited to 1) how. Tariffs are legally initiated, lol 2) who pays for Lutnick’s illegal idea of tariffs No more needed to be said …Low , scum , investment house
1 · Reply
biotech
biotech Oct. 18 at 11:56 AM
$SGMO Cantor says $TSHA roughly 1/3 $QURE market cap despite both: latestage derisking data regulatory support both sizable rare disease markets $QURE ~5-6K patients vs ~10K patients for $TSHA i say same goes for $SGMO but with 25K+ Fabry patients $SGMO marketcap 190M or 1/17 $QURE
0 · Reply
Capitulation_0
Capitulation_0 Oct. 17 at 7:52 PM
$QURE odd $NKTR too
0 · Reply